Structural and functional complexity of HSP90 in cellular homeostasis and disease

被引:61
|
作者
Chiosis, Gabriela [1 ,2 ]
Digwal, Chander S. [1 ]
Trepel, Jane B. [3 ]
Neckers, Len [4 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Chem Biol Program, New York, NY 10065 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA
[3] NCI, Dev Therapeut Branch, Ctr Canc Res, Bethesda, MD USA
[4] NCI, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20814 USA
基金
美国国家卫生研究院;
关键词
HEAT-SHOCK-PROTEIN; MOLECULAR CHAPERONE HSP90; POSTTRANSLATIONAL MODIFICATIONS; TYROSINE PHOSPHORYLATION; CONFORMATIONAL DYNAMICS; INDUCED OLIGOMERIZATION; SUBSTRATE-BINDING; CRYSTAL-STRUCTURE; ATPASE CYCLE; PHASE-I;
D O I
10.1038/s41580-023-00640-9
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Heat shock protein 90 (HSP90) is a chaperone that facilitates protein folding. In diseased cells, HSP90 and its co-chaperones form oligomers, known as epichaperomes, that confer aberrant scaffolding and holding functions onto the chaperone. Heat shock protein 90 (HSP90) is a chaperone with vital roles in regulating proteostasis, long recognized for its function in protein folding and maturation. A view is emerging that identifies HSP90 not as one protein that is structurally and functionally homogeneous but, rather, as a protein that is shaped by its environment. In this Review, we discuss evidence of multiple structural forms of HSP90 in health and disease, including homo-oligomers and hetero-oligomers, also termed epichaperomes, and examine the impact of stress, post-translational modifications and co-chaperones on their formation. We describe how these variations influence context-dependent functions of HSP90 as well as its interaction with other chaperones, co-chaperones and proteins, and how this structural complexity of HSP90 impacts and is impacted by its interaction with small molecule modulators. We close by discussing recent developments regarding the use of HSP90 inhibitors in cancer and how our new appreciation of the structural and functional heterogeneity of HSP90 invites a re-evaluation of how we discover and implement HSP90 therapeutics for disease treatment.
引用
收藏
页码:797 / 815
页数:19
相关论文
共 50 条
  • [31] Hsp90's secrets unfold: new insights from structural and functional studies
    Caplan, AJ
    TRENDS IN CELL BIOLOGY, 1999, 9 (07) : 262 - 268
  • [32] Hsp90 reaches new heightsConference on the Hsp90 Chaperone Machine
    Avrom J Caplan
    Sophie Jackson
    David Smith
    The EMBO Reports, 2003, 4 (2): : 126 - 130
  • [33] Molecular Variation of Human HSP90α and HSP90β Genes in Caucasians
    Passarino, Giuseppe
    Cavalleri, Gianpiero L.
    Stecconi, Rosalia
    Franceschi, Claudio
    Altomare, Katia
    Dato, Serena
    Greco, Valentina
    Sforza, L. Luca Cavalli
    Underhill, Peter A.
    de Benedictis, Giovanna
    HUMAN MUTATION, 2003, 21 (05)
  • [34] Clients Place Unique Functional Constraints on Hsp90
    Zuehlke, Abbey D.
    Neckers, Len
    TRENDS IN BIOCHEMICAL SCIENCES, 2016, 41 (07) : 562 - 564
  • [35] Functional association of Hsp90 with the ryanodine receptor.
    Marius, P
    Thrower, EC
    Ehrlich, BE
    BIOPHYSICAL JOURNAL, 2003, 84 (02) : 64A - 64A
  • [36] The Hsp90 ensemble: coordinated Hsp90-cochaperone complexes regulate diverse cellular processes
    Schwenkert, Serena
    Hugel, Thorsten
    Cox, Marc B.
    NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2014, 21 (12) : 1017 - 1021
  • [37] The Bacterial Hsp90 Chaperone: Cellular Functions and Mechanism of Action
    Wickner, Sue
    Nguyen, Thu-Lan Lily
    Genest, Olivier
    ANNUAL REVIEW OF MICROBIOLOGY, VOL 75, 2021, 2021, 75 : 719 - 739
  • [38] Biology of HSP90
    Workman, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 17 - 18
  • [39] Biology of HSP90
    Neckers, L.
    ANNALS OF ONCOLOGY, 2008, 19 : 17 - 17
  • [40] Modulators of HSP90
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (06) : 425 - 425